Source: centralcharts

Press Release: GenScript : GenScript Biotech and NSG Bio Form Strategic Partnership to Drive Biotechnology Innovation

GenScript Biotech and NSG Bio Form Strategic Partnership to Drive Biotechnology Innovation PR Newswire SINGAPORE, April 23, 2025 SINGAPORE , April 23, 2025

Read full article »

GenScript's Competitors | GenScript's News | GenScript's Financials

Followers on Owler

742

Annual Revenue

$500M-1.0B

Employees

5.0-10K

CEO

Zhenyu Liu

CEO Approval Rating

84/100

GenScript is a New Jersey-based biotech company that discovers, develops, and commercializes industrial synthetic products and cell therapeutic solutions.